Clinical Trial Update: Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating multiple subcutaneous doses of BCD-085 in active ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• BCD-085

Snippet

Sponsor: Biocad | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED